- $9.47bn
- $12.26bn
- $6.93bn
- 88
- 53
- 47
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,092 | 3,587 | 3,940 | 6,558 | 6,928 |
Cost of Revenue | |||||
Gross Profit | 802 | 756 | 939 | 1,721 | 1,940 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,151 | 3,753 | 3,813 | 6,391 | 6,576 |
Operating Profit | -59 | -166 | 127 | 167 | 352 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -58 | -184 | 79 | 93 | 232 |
Provision for Income Taxes | |||||
Net Income After Taxes | -67 | -153 | 47 | 73 | 153 |
Net Income Before Extraordinary Items | |||||
Net Income | -67 | -153 | 47 | 73 | 153 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -67 | -375 | -137 | 29 | -161 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.348 | -1.46 | -0.639 | 0.254 | -0.525 |
Dividends per Share |